Cargando…
VNS in drug resistant epilepsy: preliminary report on a small group of patients
BACKGROUND: In 1997 Vagus Nerve Stimulation (VNS) received approval from the US Food and Drug Administration (FDA) as an adjunctive therapy in the treatment of medically intractable partial epilepsy in people aged 12 years and older who are ineligible for resective epilepsy surgery. Although the exa...
Autores principales: | Franzoni, Emilio, Gentile, Valentina, Colonnelli, Maria Chiara, Brunetto, Daniela, Cecconi, Ilaria, Iero, Luisa, Moscano, Filomena C, Cordelli, Duccio M, Marchiani, Valentina |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2859348/ https://www.ncbi.nlm.nih.gov/pubmed/20398284 http://dx.doi.org/10.1186/1824-7288-36-30 |
Ejemplares similares
-
Post-Traumatic Headache in Children after Minor Head Trauma: Incidence, Phenotypes, and Risk Factors
por: Dondi, Arianna, et al.
Publicado: (2023) -
Similarities between the responses to ANT‐DBS and prior VNS in refractory epilepsy
por: Kulju, Toni, et al.
Publicado: (2018) -
Cytogenetic and molecular characterization of a recombinant X chromosome in a family with a severe neurologic phenotype and macular degeneration
por: Magini, Pamela, et al.
Publicado: (2015) -
Model Phrases for VNs
por: Department, HR
Publicado: (2011) -
Evolution of the Vagus Nerve Stimulation (VNS) Therapy System Technology for Drug-Resistant Epilepsy
por: Afra, Pegah, et al.
Publicado: (2021)